The Venture Collective
Miami Beach · Series A
Investment thesis
The Venture Collective seeks to invest in highly defensible, category-defining, mission-driven companies addressing major global challenges. The firm prioritizes working with founders who champion diversity, equity, and inclusion, viewing this as both a strong investment thesis and a major impact opportunity. As an early-stage investor, the firm emphasizes active support through the critical period between inception and product-market fit, leveraging team expertise to drive better outcomes for founders and investors alike.
Source: firm website, verified Jul 21, 2026.
What they invest in
from 17 of 112 portfolio companiesAI & Machine Learning ×7Biotech ×7Healthtech ×7FoodTech ×4Circular Economy ×3Climate Tech ×3Deep Tech ×3Digital Health ×3
HQs:United Kingdom×4United States×4Germany×1
Investments · showing 60 of 112
founders shown can be your intro pathPharmacy of the future offering natural alternatives to pharmaceuticals
Convenient and affordable access to everyday medicines in Bangladesh
Commercial space station missions and operations
Axiom Space develops commercial space stations and provides access to low-Earth orbit microgravity environments for research, manufacturing, and innovation by governments, researchers, and organizations.
Defense TechEdTechHardwareSpace Tech
Dr. Kam Ghaffarian(Executive Chairman)Michael Suffredini(Founder, former CEO and President)
100% plant-based tuna alternatives with sea proteins
Neural engineering solutions to improve quality of life
BIOS develops neural digital therapy technology to deliver treatments for neurological conditions. The company combines neural engineering with AI and machine learning to improve healthcare outcomes and restore patient control over bodily function.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesCambridge, GB
Behavioral telehealth platform for underserved Medicare and Medicaid populations
Powerful enzymatic solutions for sustainable chemical production
Mental, physical, and reproductive health services for Gen Z
Cocoon manufactures LoopCem™, a low-carbon supplementary cementitious material made from electric arc furnace slag waste, enabling cement and concrete producers to reduce embodied CO₂ by up to 27% without cost premium. The company operates within the steel and cement industries to address their combined 14% share of global CO₂ emissions.
Circular EconomyCleantechClimate TechLondon, GB
Low-carbon construction materials for sustainable building
First biostimulant created for soilless agriculture
Individualized pet health technology
Wealth management and financial planning services optimized for women
Science-backed consumer longevity products
Elysium develops healthcare products focused on aging research and healthy aging rather than disease treatment. The company translates aging research into accessible solutions for individuals seeking to improve their long-term health outcomes.
HealthtechLongevityWellness & Fitness
Leonard Guarente, Ph.D.(Co-founder & Chief Scientist)
Expanding library of psychedelics to treat mental illness
Automation and scale-up technology for insect farming
Entocycle uses industrial automation and machine learning to convert organic waste into animal and plant feed by breeding black soldier fly larvae at scale. The company addresses protein demand and food waste in global agriculture and aquaculture.
Advanced ManufacturingAgTechBiotechCircular EconomyFoodTechLondon, GB
Keiran Olivares Whitaker(Founder)inJames Millar(CEO)
Protein discovery platform for fast, cheap, and predictable engineering biology
Epoch Biodesign develops enzyme recycling technology powered by AI to break down plastic and textile waste into virgin-grade chemical building blocks. The company serves the fashion, apparel, and automotive industries pursuing textile-to-textile and plastic circularity.
AI & Machine LearningBiotechCircular EconomyClimate Tech
Jacob
Stopping age from causing disease
Data-driven, turnkey platform for tackling obesity
Fork & Good develops cultivated meat technology using a hydroponic system approach that integrates cell biology with farming principles to produce real meat from cells at scale. The company serves food manufacturers and works toward making cultivated meat commercially viable and sustainable.
BiotechDeep TechFoodTech
Gabor Forgacs(Chief Scientific Officer and co-founder)Andras Forgacs(Partner and co-founder)Niya Sharma(Co-founder)
Scaling cultivated meat production to deliver affordable, sustainable pork
Developing first space outpost with artificial gravity capabilities
Nicotine addiction treatment through automatic, gradual substance weaning
Automating library prep to bring next-gen sequencing to the point of care
Helix Nanotechnologies develops mRNA-based therapeutics for disease treatment and environmental applications, currently advancing a COVID-19 vaccine candidate for immunocompromised patients and testing interventions targeting climate challenges.
AI & Machine LearningBiotechHealthtechBoston, US
Nikolai Eroshenko(Founder/CSO)in
Synthetic biology for mRNA therapeutics targeting deadly cancers and diseases
Engineered cell therapy platform to treat retinal degeneration
Immunotherapy platform addressing limitations of traditional CAR-T therapies
Longevity company with diversified therapies to extend healthy human lifespan
Enabling farmers to capture carbon cost-effectively via biochar
Lowest rate option for SMB payments with flexible settlement
Revolutionizing biomanufacturing with tissue-engineered bioreactors
Comprehensive autonomous solutions for off-road industries
Trusted healthcare expert marketplace matching experts with clients
First patented, non-toxic repellent with DEET efficacy
Frequently asked questions
- What stage does The Venture Collective invest at?
- The Venture Collective invests at the Series A stage.
- What sectors does The Venture Collective focus on?
- The Venture Collective focuses on Sector Agnostic.
- Where is The Venture Collective located?
- The Venture Collective is headquartered in Miami Beach, US.
Similar investors
3TS Capital is a technology investment firm with over 25 years of experience managing multiple fund generations. The firm partners with exceptional founders to scale internationally, targeting high-growth SMEs that are either proven local leaders or innovative global challengers.
500 Global's Sustainable Growth practice designs and implements sovereign-aligned strategies that unlock resilient, inclusive, and sustainable economic growth across the Global Majority—Asia, Africa, Latin America, and the Middle East. The practice bridges public priorities and private capital through ecosystem development, blended finance, and localized innovation programs addressing health, agriculture, gender, climate, and education.
83North is a lean venture capital partnership of four equal general partners that has operated for 19 years. The firm invests globally across the US, Europe, and Israel, and in 2025 raised what it describes as its final fund, shifting focus toward selectively pursuing new opportunities while supporting existing portfolio companies.
8VC is a technology investment firm focused on building and investing in ambitious companies across life sciences, healthcare, manufacturing, enterprise, logistics, and defense sectors, with particular emphasis on operational intelligence and data-driven decision-making.
Accomplice is a venture capital firm that operates a federated model, serving as anchor LPs for solo GP funds and operating affiliated investment programs including Spearhead, an operator-angel network, and Accomplice Blockchain.